Natia Esiashvili MD
Overview
A board certified radiation oncologist, Natia Esiashvili, MD, practices general radiation oncology and specializes in the treatment of pediatric cancer, brain and spine tumors, sarcoma lymphoma Leukemia, and bone marrow and stem cell transplantation. Dr. Esiashvili treats patients at Winship Cancer Institute of Emory University and Emory Proton Therapy Center. She leads the pediatric radiation oncology service at Winship, the only center performing total body irradiation for bone marrow transplantation in Georgia. She specializes in the treatment of complex pediatric cancers and hematological malignancies in adults.
Dr. Esiashvili serves as president of the Paediatric Radiation Oncology Society where she also served on an executive committee leading programs for low- and middle-income countries worldwide. She is a member of the American Society of Therapeutic Radiation Oncology, American Society of Clinical Oncology, American College of Radiology, and Children's Oncology Group, among others.
Dr. Esiashvili earned her MD from Tbilisi State Medical University in her home country, the Republic of Georgia. She completed her residency in radiation oncology at Emory University Hospital in Atlanta where she served as chief resident.
Dr. Esiashvili is the recipient of an international scholarship grant from the American Society of Therapeutic Radiation Oncology. She has received various awards for her work in radiation oncology as well as spoken at a number of national and international conferences. In 2017, she was listed in Atlanta Magazine's "Top Doctors" issue.
Dr. Esiasvhili's research tracks the clinical outcomes of children treated with modern radiotherapy techniques such as intensity-modulated radiation therapy and frameless radiosurgery. She helped design radiotherapy guidelines for several clinical trials for the Children's Oncology Group. As a member of the Childrens Oncology Group Late Effects Guidelines Task Force, she collaborates with clinical investigators across the country to develop evidence-based screening and follow-up guidelines for survivors of childhood tumors. Dr. Esiashvili received a grant for researching long-term follow-up care in young adult cancer survivors and established the first transitional clinic for survivors of childhood malignancies in Georgia.
As a field expert, she has spoken at a number of national and international conferences and participated in committees and working groups charged with developing treatment guidelines, clinical trials and late effects screening guidelines.
Dr. Esiashvili serves as a manuscript reviewer for the International Journal of Radiation Oncology and has published several journal articles and book chapters.
Academic Appointment
- Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine
Education
Degrees
- MD from Tbilisi State Medical University
- No Degree from Emory University School of Medicine
Research
Focus
- My main research focuses are in clinical outcomes of patient treated with radiotherapy for pediatric tumors, late effects in pediatric cancer survivors, cardio-vascular late effects in cancer survivors, outcomes of lymphoid malignancies
Publications
-
Twenty Years of the Paediatric Radiation Oncology Society.
Pediatr Blood Cancer Volume: 72 Page(s): e31764
07/01/2025 Authors: Gaze MN; Beldjoudi G; Carrie C; Freeman C; Indelicato DJ; Kortmann R-D; Kristensen I; Laprie A; Lassen Y; Mahajan A -
Risks of Spinal Abnormalities and Growth Impairment After Radiation to the Spine in Childhood Cancer Survivors: A PENTEC Comprehensive Review.
Int J Radiat Oncol Biol Phys Volume: 119 Page(s): 507 - 521
06/01/2024 Authors: Nanda RH; Hua C-H; Flampouri S; Eaton B; Kaste S; Patni T; Ronckers C; Constine LS; Marks LB; Esiashvili N -
Indoximod-based chemo-immunotherapy for pediatric brain tumors: A first-in-children phase I trial.
Neuro Oncol Volume: 26 Page(s): 348 - 361
02/02/2024 Authors: Johnson TS; MacDonald TJ; Pacholczyk R; Aguilera D; Al-Basheer A; Bajaj M; Bandopadhayay P; Berrong Z; Bouffet E; Castellino RC -
Establishment of Twinning Partnership to Improve Pediatric Radiotherapy Outcomes Globally.
JCO Glob Oncol Volume: 10 Page(s): e2300345
02/01/2024 Authors: Ali N; Amare E; Fekadu A; Awol M; Kayode O; Gebresenbet M; Nasir K; Dresser SA; Schriebmann E; Seife E -
The impact of radiation therapy variables on pediatric high-grade glioma outcomes: A National Cancer Database analysis.
Pediatr Blood Cancer Volume: 71 Page(s): e30751
01/01/2024 Authors: Williamson C; Williamson S; Jiang R; Sudmeier L; Esiashvili N; Eaton BR -
SIOP PODC-adapted treatment guidelines for craniopharyngioma in low- and middle-income settings.
Pediatr Blood Cancer Volume: 70 Page(s): e28493
11/01/2023 Authors: Amayiri N; Spitaels A; Zaghloul M; Figaji A; Cavalheiro S; Muller HL; Elhassan M; Parkes J; Mushtaq N; Beltagy ME -
Impact of COVID-19 pandemic on delivery of pediatric radiotherapy: A critical review.
Volume: 70 Page(s): e30446
08/31/2023 Authors: Ali N; Ghalibafian M; Sykes-Martin K; Parkes J; Qureshi B; Esiashvili N -
Impact of Age on Overall Survival Among Children With Wilms Tumor: A Population-based Registry Analysis.
Volume: 46 Page(s): 213 - 218
05/01/2023 Authors: Qian DC; Sykes-Martin KD; Tobillo R; Ali N; Wynne JF; Eaton BR; Paulino AC; Kalapurakal JA; Esiashvili N -
Central nervous system status is prognostic in T-cell acute lymphoblastic leukemia: a Children's Oncology Group report.
Blood Volume: 141 Page(s): 1802 - 1811
04/13/2023 Authors: Gossai NP; Devidas M; Chen Z; Wood BL; Zweidler-McKay PA; Rabin KR; Loh ML; Raetz EA; Winick NJ; Burke MJ -
Palliative radiotherapy for children: Symptom response and treatment-associated toxicity according to radiation therapy dose and fractionation.
Pediatr Blood Cancer Volume: 70 Page(s): e30195
04/01/2023 Authors: Sudmeier LJ; Madden N; Zhang C; Brock K; Esiashvili N; Eaton BR